These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 965964)

  • 21. Acute and chronic effects of delta9-tetrahydrocannabinol on food intake by rats.
    Sofia RD; Barry H
    Psychopharmacologia; 1974; 39(3):213-22. PubMed ID: 4427988
    [No Abstract]   [Full Text] [Related]  

  • 22. The effects of chronic treatment with delta 9-tetrahydrocannabinol on catecholamine synthesis in the rat.
    Mazurkiewicz-Kwilecki IM; Filczewski M
    Psychopharmacologia; 1973 Oct; 33(1):71-9. PubMed ID: 4797647
    [No Abstract]   [Full Text] [Related]  

  • 23. [Fatty acid and sphingosine base composition of gangliosides from rat brain subcellular fractions].
    Avrova NF; Obukhova EL; Chenykaeva EIu
    Zh Evol Biokhim Fiziol; 1972; 8(5):549-53. PubMed ID: 4668753
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of delta-9-tetrahydrocannabinol on halothane MAC in dogs.
    Stoelting RK; Martz RC; Gartner J; Creasser C; Brown DJ; Forney RB
    Anesthesiology; 1973 Jun; 38(6):521-4. PubMed ID: 4706747
    [No Abstract]   [Full Text] [Related]  

  • 25. A comparison of the pharmacological activity of delta 9-tetrahydrocannabinol and its monohydroxylated metabolites in man.
    Perez-Reyes M; Timmons MC; Lipton MA; Christensen HD; Davis KH; Wall ME
    Experientia; 1973 Aug; 29(8):1009-10. PubMed ID: 4582081
    [No Abstract]   [Full Text] [Related]  

  • 26. Hypothermic action of delta 9-tetrahydrocannabinol, 11-hydroxy-delta 9-tetrahydrocannabinol and 11-hydroxy-delta 8-tetrahydrocannabinol in mice.
    Haavik CO; Hardman HF
    Life Sci; 1973 Dec; 13(12):1771-8. PubMed ID: 4777336
    [No Abstract]   [Full Text] [Related]  

  • 27. Further evidence for a role of 2-phenylethylamine in the mode of action of delta 9-tetrahydrocannabinol.
    Sabelli HC; Pedemonte WA; Whalley C; Mosnaim AD; Vazquez AJ
    Life Sci; 1974 Jan; 14(1):149-56. PubMed ID: 4810493
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of oral delta9-tetrahydrocannabinol on operant reinforcement schedule performance in rats.
    Ferraro DP; Gluck JP
    Pharmacology; 1974; 11(2):65-9. PubMed ID: 4829291
    [No Abstract]   [Full Text] [Related]  

  • 29. Letter: Suppression of the cyclic surge of luteinizing hormone secretion and of ovulation in the rat by delta 1-tetrahydrocannabinol.
    Nir I; Ayalon D; Tsafriri A; Cordova T; Lindner HR
    Nature; 1973 Jun; 243(5408):470-1. PubMed ID: 4582754
    [No Abstract]   [Full Text] [Related]  

  • 30. Tetrahydrocannabinol, sesame oil and biogenic amines: a preliminary report.
    Anton AH; Serrano A; Beyer RD; Lavappa KS
    Life Sci; 1974 May; 14(9):1741-6. PubMed ID: 4407739
    [No Abstract]   [Full Text] [Related]  

  • 31. Delta-8- and delta-9-tetrahydrocannabinol comparison in man by oral and intravenous administration.
    Hollister LE; Gillespie HK
    Clin Pharmacol Ther; 1973; 14(3):353-7. PubMed ID: 4698563
    [No Abstract]   [Full Text] [Related]  

  • 32. Relative pharmacological potency in mice of optical isomers of delta 1-tetrahydrocannabinol.
    Jones G; Pertwee RG; Gill EW; Paton WD; Nilsson IM; Widman M; Agurell S
    Biochem Pharmacol; 1974 Jan; 23(2):439-46. PubMed ID: 4813356
    [No Abstract]   [Full Text] [Related]  

  • 33. Depth perception in rats following acute or chronic injections of D1- 9 tetrahydrocannabinol.
    Fried PA; Husband CA
    Life Sci I; 1973 Apr; 12(7):289-95. PubMed ID: 4695123
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of acute and chronic pretreatment with delta1-tetrahydrocannabinol on motor impairment by ethanol in the rat.
    Kalant H; LeBlanc AE
    Can J Physiol Pharmacol; 1974 Apr; 52(2):291-7. PubMed ID: 4838189
    [No Abstract]   [Full Text] [Related]  

  • 35. 1- 9 -Tetrahydrocannabinol--effects on the urinary excretion of 5-hydroxyindole acetic acid.
    Pal B; Ghosh JJ
    Biochem Pharmacol; 1972 Jan; 21(2):263-4. PubMed ID: 4645557
    [No Abstract]   [Full Text] [Related]  

  • 36. Changes in rat brain energetic metabolism after exposure to anandamide or Delta(9)-tetrahydrocannabinol.
    Costa B; Colleoni M
    Eur J Pharmacol; 2000 Apr; 395(1):1-7. PubMed ID: 10781666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential neurochemistry and temporal pattern in rats treated orally with delta9-tetrahydrocannabinol for periods up to six months.
    Luthra UL; Rosenkrantz H; Heyman IA; Braude MC
    Toxicol Appl Pharmacol; 1975 May; 32(2):418-31. PubMed ID: 1171540
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of delta9-tetrahydrocannabinol on the uptake and release of 14C-dopamine from crude striatal synaptosoma; preparations.
    Howes J; Osgood P
    Neuropharmacology; 1974 Dec; 13(12):1109-14. PubMed ID: 4457762
    [No Abstract]   [Full Text] [Related]  

  • 39. Age-related changes in the ceramide composition of the major gangliosides present in rat brain subcellular fractions enriched in plasma membranes of neuronal and myelin origin.
    Palestini P; Masserini M; Fiorilli A; Calappi E; Tettamanti G
    J Neurochem; 1993 Sep; 61(3):955-60. PubMed ID: 8360694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of delta-9-tetrahydrocannabinol on cyclopropane MAC in the rat.
    Vitez TS; Way WL; Miller RD; Eger EI
    Anesthesiology; 1973 Jun; 38(6):525-7. PubMed ID: 4706748
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.